These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Therapy of extrapyramidal-motor symptoms. Drug treatment]. Hartmann-von Monakow K Bibl Psychiatr Neurol; 1969; 139():697-704. PubMed ID: 5406928 [No Abstract] [Full Text] [Related]
3. [Phenomenology of the most important pyramidal and extrapyramidal motoric syndromes. Indications for surgery and results. I]. Mundinger F Z Allgemeinmed; 1974 Jun; 50(18):827-37. PubMed ID: 4277897 [No Abstract] [Full Text] [Related]
6. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics]. Degkwitz R Med Klin; 1969 Aug; 64(33):1451-6. PubMed ID: 4896563 [No Abstract] [Full Text] [Related]
7. The pharmacology of extrapyramidal movement disorders. Klawans HL Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860 [No Abstract] [Full Text] [Related]
9. Clinical and electroencephalographical studies in patients with involuntary movements. Kitagawa T Yonago Acta Med; 1972 Nov; 15(3):225-33. PubMed ID: 5028949 [No Abstract] [Full Text] [Related]
10. Involuntary movement disorders. Still CN Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of Parkinson's syndrome with L-dopa]. Kaeser HE; Ferel D; Wurmser P Schweiz Med Wochenschr; 1970 May; 100(19):805-13. PubMed ID: 4924276 [No Abstract] [Full Text] [Related]
12. Conray ventriculography in stereotaxic surgery experience with 320 operations. Kandel E; Chebotaryova NM Confin Neurol; 1972; 34(2):34-40. PubMed ID: 4269360 [No Abstract] [Full Text] [Related]
13. Network biomarkers for the diagnosis and treatment of movement disorders. Poston KL; Eidelberg D Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242 [TBL] [Abstract][Full Text] [Related]
14. [Immediate results of treating extrapyramidal hyperkinesias with stereotaxic surgery]. Laponogov OA Vopr Neirokhir; 1969; 33(1):12-7. PubMed ID: 4891581 [No Abstract] [Full Text] [Related]
15. [Electroencephalographic changes in patients with extrapyramidal syndromes prior to and following stereotaxic surgery]. Stadnicki R; Mempel E; Bacia T Neurol Neurochir Pol; 1971; 5(1):55-61. PubMed ID: 4251001 [No Abstract] [Full Text] [Related]
16. Drugs and motor functions. Gordon N Dev Med Child Neurol; 1971 Jun; 13(3):384-6. PubMed ID: 4398415 [No Abstract] [Full Text] [Related]
17. Therapeutics of disordered movement. Sears ES Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204 [TBL] [Abstract][Full Text] [Related]
18. Neutralization of extrapyramidal side-effects with Methixene. Maller O; Heller S Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695 [No Abstract] [Full Text] [Related]
19. EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS. MARKHAM CH; CLARK WG; WINTERS WD Life Sci (1962); 1963 Sep; 9():697-705. PubMed ID: 14068044 [No Abstract] [Full Text] [Related]
20. [Priniciples of diagnosis and treatment of patients with extrapyramidal disorders and epilepsy with the use of deep long lasting electrodes]. Ugriumov VM; Vvedenskaia IV; Grachev KV; Stepanova TS; Iatsuk SL Vopr Neirokhir; 1967; 31(6):20-6. PubMed ID: 5597684 [No Abstract] [Full Text] [Related] [Next] [New Search]